The mechanism of action of benzydamine on local infectious inflammation


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Local infectious and inflammatory diseases are one of the most common pathologies in medical practice; for example, tonsillopharyngitis is a disease that is extremely common in a physician’s routine practice. To date, there are many drugs designed to the treatment of tonsillopharyngitis at the market. However, these agents have a different pharmacological effects necessary for correct therapy. In gynecological practice, infectious and inflammatory diseases of the vulva and vagina, such as specific and non-specific vulvovaginitis are one of the most frequent problems. For the topical pharmacotherapy of infectious and inflammatory diseases in gynecology, a large number of drugs with different mechanisms of action are also offered. The authors identify key mechanisms of acute and chronic inflammation, which should be affected by these drugs due to their pharmacokinetic and pharmacodynamic properties. Benzydamine hydrochloride has a pronounced antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as fungi of the genus Candida (albicans and non-albicans species), which allows to militate against etiological agent of infectious and inflammatory diseases. Also, benzydamine hydrochloride refers to the so-called «cytokine» non-steroidal anti-inflammatory drugs that are able to suppress the inflammatory process without inhibiting cyclooxygenase (COX), which does not lead to the development of side effects associated with an excessive decrease in the prostaglandin levels. The biological aspects of the interaction of drugs with various links of local immunity are also discussed; the use of benzydamine hydrochloride for local therapy of acute and chronic infectious and inflammatory processes is pathogenetically substantiated.

全文:

受限制的访问

作者简介

G. Poryadin

N.I. Pirogov Russian National Research Medical University

Department of Pathophysiology and Clinical Pathophysiology

Jean Salmasi

N.I. Pirogov Russian National Research Medical University

Email: profjms@yandex.ru
MD, Professor, Head of the Department of Pathophysiology and Clinical Pathophysiology 1, Ostrovityanov Street, Moscow 117997, Russian Federation

A. Kazimirsky

N.I. Pirogov Russian National Research Medical University

Department of Pathophysiology and Clinical Pathophysiology

参考

  1. Daifalla N., Cayabyab M.J., Xie E., et al. Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination. Microb. Infect. 2015;17(3):237-42. doi: 10.1016/j.micinf.2014.11.002.
  2. Engen S.A., Rukke H.V., Becattini S., et al. The Oral Commensal Streptococcus mitis Shows a Mixed Memory Th Cell Signature That Is Similar to and Cross-Reactive with Streptococcus pneumoniae. PLoS One. 2014;9(8):e 104306. Doi: 10.1371/ journal.pone.0104306.
  3. Iwase T., Uehara Y., Shinji H., et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465(7296):346-49. Doi: 10.1038/ nature09074.
  4. Chen H.W., Liu P.F., Liu Y.T., et al. Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Sci. Rep. 2016;6:27870. Doi: 10.1038/ srep27870.
  5. Quane P.A., Graham G.G., Ziegler J.B. Pharmacology of benzydamine. Inflammopharmacol. 1998;6(2):95-107. doi: 10.1007/s10787-998-0026-0.
  6. Maamer M., Aurousseau M., Colau J.C. Concentration of benzydamine in vaginal mucosa following local application: an experimental and clinical study. Int. J. Tissue React. 1987;9(2): 135-45.
  7. Hemalatha R., Ramalaxmi B.A., Krishna Swetha G., et al. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis. Am.J. Med. Sci. 2012;344(1):35- doi: 10.1097/MAJ.0b013e318235597b.
  8. Брико Н.И., Фурсова Н.К., Слукин П.В. и др. Влияние бензидамина на планктонные клетки и биопленки клинических изолятов бактерий и грибов, выделенных у российских пациентов. Эпидемиология и вакцинопрофилактика. 2018;6.
  9. Marconi C., Santos-Greatti M.M., Parada C.M., et al. Cervicovaginal levels of proinflammatory cytokines are increased during chlamydial infection in bacterial vaginosis but not in lactobacilli-dominated flora. J. low Genit. Tract. Dis. 2014;18(3):261-65. doi: 10.1097/LGT.0000000000000003.
  10. Santos-Greatti M.M.V., da Silva M.G., Ferreira C.S.T., Marconi C. Cervicovaginal cytokines, sialidase activity and bacterial load in reproductive-aged women with intermediate vaginal flora. J. Reprod. Immunol. 2016;118:36-41. Doi: 10.1016/j. jri.2016.08.005.
  11. Ferreira C.S., Marconi C., Parada C.M., et al. Bacterial vaginosis in pregnant adolescents: proinflammatory cytokine and bacterial sialidase profile. Cross-sectional study Sao Paulo Med. J. 2015;133(6):465-70. doi: 10.1590/1516-3180.2014.9182710.
  12. Vick E.J., Park H.S., Huff K.A., Brooks K.M., Farone A.L., Farone M.B. Gardnerella vaginalis triggers NLRP3 inflammasome recruitment in THP-1 monocytes. J. Reprod. Immunol. 2014;106:67-75. doi: 10.1016/j.jri.2014.08.005.
  13. Broz P. Immunology: Caspase target drives pyroptosis. Nature. 2015;526(7575):642-43. Doi: 10.1038/ nature15632.
  14. Kremleva E.A., Bukharin O.V. Effect of IL-1beta on growth properties of vaginal microsymbionts. Zh. Mikrobiol. Epidemiol. Immunobiol. 2013;(4):65-9.
  15. Mitchell C., Fredricks D., Agnew K., Hitti J. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1ß, Independent of Bacterial Vaginosis. Sex. Transm. Dis. 2015;42(7):358-63. Doi: 10.1097/ 0LQ.0000000000000298.
  16. Verstraelen H., Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr. Opin. Infect. Dis. 2013;26(1):86-9. Doi: 10.1097/ QCO.0b013e32835c20cd.
  17. Molinari G.L., Andreoni S., Fortina G. Attivita battericida e fungicida "in vitro" di benzidamina cloridrato. Microbiol. Med. 1993;8(20):180-83.
  18. Prats G. Determination of Benzydamine antibacterial activity against clinical strains: an in vitro study Servicio de Microbiologia, Hospital de Sant Pau, 08025 Barcelona, 2001, study of Angelini ACRAF S.p.A. #8655U01.
  19. Czajka R., Torbè A. Assessment of the efficacy of benzydamine (Tantum Rosa) in form of vaginal of perineal complaints in the early puerperium. Pol. J. Gyn. Invest. 2001;4(2):99-105.
  20. Обоскалова Т.А. Кононова И.Н., Ворошилина Е.С., Тагинцева М.Л. Особенности современного течения инфекционных процессов половых путей у женщин и пути их коррекции. Эффективная фармакотерапия. Акушерство и гинекология. 2012;5:6-10.
  21. Кузьмин В.Н. Принципы ведения родильниц в раннем послеродовом периоде. Вопросы гинекологии, акушерства и перинатологии. 2010;9(6):47-51

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2018
##common.cookie##